Instruments

Name Stock exchange Average volume Price Type
LEVI STRAUSS & CO. LEVI

Nyse +9 Other

1,448,749 23.53 USD Stock Levi Strauss & Co. Stock
LEVI STRAUSS & CO. LV2B

Deutsche Boerse AG

- 21.76 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

Börse Stuttgart

- 21.79 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LEVI

Wiener Boerse

- 21.98 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. 0A14

London S.E.

306 16.62 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LEVI *

Mexican S.E.

428 406 MXN Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

Frankfurt

188 18.7 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

BOERSE MUENCHEN

- 21.76 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. 1LEVI

Borsa Italiana

- 21.78 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

Berne S.E.

- - CHF Stock Levi Strauss & Co.
RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD RMLI

TEL AVIV STOCK EXCHANGE +1 Other

30,368 19,800 ILa Stock Rami Levi Chain Stores Hashikma Marketing 2006 Ltd Stock
RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD RLEVF

OTC Markets

135 67.95 USD Stock Rami Levi Chain Stores Hashikma Marketing 2006 Ltd
LEVI STRAUSS & CO. LV2C

BOERSE MUENCHEN

- 87.11 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

Deutsche Boerse AG

- 97.64 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

Deutsche Boerse AG

- 97.66 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

BOERSE MUENCHEN

- 98.22 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO. LV2C

Börse Stuttgart

- 86.36 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

Börse Stuttgart

- 97.13 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

BOERSE MUENCHEN

- 98.29 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO. LV2C

Deutsche Boerse AG

- 86.66 % Bond Levi Strauss & Co. Bond

News (506)

Roche: EU approval for lung cancer CF
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer GL
Five-year Data for Genentech’s Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy (SMA) Achieved or Maintained the Ability to Sit, Stand or Walk BU
Five-year data for Roche’s Evrysdi show the majority of treated children with a severe form of spinal muscular atrophy (SMA) achieved or maintained the ability to sit, stand or walk GL
FDA Grants Priority Review to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation BU
FDA grants Priority Review to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GL
FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation BU
FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GL
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial -- Update DJ
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial DJ
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity BU
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity GL
Roche: positive CHMP opinion for Alecensa CF
FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer GL
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer BU
Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS BU
Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS GL
Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study BU
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study GL
Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care GL
New England Journal of Medicine Publishes Phase III Data Showing Xolair Significantly Reduced Allergic Reactions Across Multiple Foods in People With Food Allergies BU
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies GL
Roche: FDA approves allergy treatment CF
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies GL
FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies BU
New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO) BU
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO) GL
European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types GL
Roche's Xolair Granted FDA Priority Review DJ
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results GL
FDA Grants Priority Review to Xolair (omalizumab) for Children and Adults With Food Allergies Based on Positive National Institutes of Health Phase III Study Results BU
New data for Roche’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma GL
New Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With Lymphoma BU
New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A BU
New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A GL
Roche's Inavolisib Breast Cancer Drug Gets Positive Results DJ
Roche: positive data for Kadcyla in breast cancer CF
Roche's Kadcyla is the first targeted therapy to show significant overall survival benefit in people with HER2-positive early-stage breast cancer with residual invasive disease after neoadjuvant treatment GL
Roche’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GL
Genentech’s Kadcyla Is the First Targeted Therapy to Show Significant Overall Survival Benefit in People With HER2-Positive Early-Stage Breast Cancer With Residual Invasive Disease After Neoadjuvant Treatment BU
Genentech’s Inavolisib Combination Reduces the Risk of Disease Progression by 57% in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation BU
Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GL
Genentech Announces Positive Phase III Results for Inavolisib Combination in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation BU
Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- Update DJ
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes GL
1234NextSee all

Companies (16)

SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. 33 659 M $
Logo Shanghai Pudong Development Bank Co., Ltd.

Shanghai Pudong Development Bank Co., Ltd. is a commercial bank. The group specializes in commercial loans and public deposits levying. At the end of 2020, Shanghai Pudong Development Bank manages CNY 4,122.4 billion of current deposits and CNY 4,430.2 b ...

LEVI STRAUSS & CO. 9 366 M $
Logo Levi Strauss & Co.

Levi Strauss & Co. is an apparel company. The Company designs and markets jeans, casual wear and related accessories for men, women and children under the Levi's, Signatureby Levi Strauss & Co., Denizen, Dockers and Beyond Yoga brands. The Company operate ...

RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD 734 M $
Logo Rami Levi Chain Stores Hashikma Marketing 2006 Ltd

Rami Levi Chain Stores Hashikma Marketing 2006 Ltd. is an Israel-based discount chain store which operates 14 branches in Jerusalem as well as in the surrounding areas of Shilat (Modiin), Mishor Adomim, Mevaseret Zion and Shaar Benyamin. The Company opera ...

SUN HING VISION GROUP HOLDINGS LIMITED 24 M $
Logo Sun Hing Vision Group Holdings Limited

Sun Hing Vision Group Holdings Limited is a Hong Kong-based investment holding company principally engaged in glasses-related businesses. The main businesses of the Company include the design, manufacture and sales of glasses and other related eyewear pro ...

CRYSTAL INTERNATIONAL GROUP LIMITED 1 457 M $
Logo Crystal International Group Limited

Crystal International Group Limited is a company principally engaged in the manufacture and distribution of clothes. The Company’s Products are divided into five categories, namely casual wear, personal underwear, sweaters and sportswear and outdoor clo ...

HYBRID FINANCIAL SERVICES LIMITED 4 M $
Logo Hybrid Financial Services Limited

Hybrid Financial Services Limited is an India-based company. The Company is engaged in the business activities of management consulting, which consists of debt recovery advise, consultancy in financial, secretarial, commercial, legal, direct and indirect ...

CREDO BRANDS MARKETING LIMITED 125 M $
Logo Credo Brands Marketing Limited

Credo Brands Marketing Ltd is an India-based company, which is engaged in in the business of selling of fashion casual garments and accessories under the brand name MUFTI. The Company operates in the men’s casual wear and apparels business segment. Its ...

PT MEGA PERINTIS TBK 59 M $
Logo PT Mega Perintis Tbk

PT Mega Perintis Tbk is an Indonesia-based apparel company. The Company is engaged in retail trading of apparels with a focus on men’s fashion. The Company operates under various brands, namely MANZONE that offers men’s apparel; MOC offers contemporar ...

NICHOLS PLC 467 M $
Logo Nichols plc

Nichols plc is an international soft drinks company. The Company is engaged in the supply of soft drinks to the retail, wholesale, catering, licensed and leisure industries. It has sales in over 73 countries, selling products in both the Still and Carbona ...

WA KAOLIN LIMITED 14 M $
Logo WA Kaolin Limited

WA Kaolin Limited is an Australia-based mineral exploration, extraction and processing company. The Company's principal activities are the exploration and development of an inferred mineral resource of high-grade premium kaolinized granite, proprietary pr ...

SOLIDUS COMMUNICATIONS INC. 460 964 $
Logo Solidus Communications Inc.

Solidus Communications, Inc. is specializing in the acquisition of technology infrastructure companies, comprised of Advanced Satellite Systems, Inc. and WiFIBER CORP. Advanced Satellite Systems, Inc. is a provider of Internet and television services to h ...

JAMAICA BROILERS GROUP LIMITED 219 M $
Logo Jamaica Broilers Group Limited

Jamaica Broilers Group Limited is a Jamaica-based company. The principal activities of the Company and its subsidiaries include the production and distribution of poultry products, animal feeds and agricultural items. The Company operates through three se ...

GENESCO INC. 303 M $
Logo Genesco Inc.

Genesco Inc. is a retailer and wholesaler of branded footwear, apparel and accessories. The Company’s segments include Journeys Group, Schuh Group, Johnston & Murphy Group and Genesco Brands Group. The Journeys Group segment comprises the Journeys, Jour ...

TILLY'S, INC. 169 M $
Logo Tilly's, Inc.

Tilly's, Inc. is a specialty retailer of casual apparel, footwear, accessories, and hardgoods for young men, young women, boys and girls. The Company’s stores are located in a variety of retail centers, including malls, lifestyle centers, power centers, ...

THE BUCKLE, INC. 1 843 M $
Logo The Buckle, Inc.

The Buckle, Inc. is a retailer of casual apparel, footwear, and accessories. The Company operates approximately 440 retail stores in 42 states. The Company markets a wide selection of casual apparel including denim, other casual bottoms, tops, sportswear, ...

SEARS HOLDINGS CORPORATION 11 M $
Logo Sears Holdings Corporation

Sears Holdings Corp is a United States-based company. The Company is an integrated retailer with approximately 766 full-line and specialty retail stores. It operates through two segments: Kmart and Sears Domestic. Its Kmart segment offers a range of produ ...


12Next

Insiders

Picture Levi Garraway
Levi Garraway

Levi A.
Garraway
is the founder of Foundation Medicine, Inc. (founded in 2009) and Tango Therapeutics Sub, Inc. (founded in 2017).
He is currently the Director, Chief Medical Officer & Executive VP at Genentech, Inc. since 2019 and the Chief Medical Officer & Head-Product Development at Roche Holding AG.
Dr. Garraway's former positions include being the Director at the American Association for Cancer Research, Senior VP-Global Development & Medical Affairs at Eli Lilly & Co. from 2017 to 2019, and Assistant Professor at Dana-Farber Cancer Institute, Inc. from 2007 to 2011.


Picture Pierre Levi
Pierre Levi

Pierre Levi is currently an Independent Director at Global Bioenergies SA, a Director at B Cell Design SAS, a Director at Rispa, and a Co-Manager at Metman Capital SARL.
Previously, he held positions such as Chairman & Chief Executive Officer at Forvia SE, Chief Executive Officer at Compagnie des Salins du Midi et des Salines de l'Est SASU, Deputy Chairman at Solvay France SA, and Deputy Chairman at Rhone-Poulenc SA. He also served as a Director at Ayming SAS, Kowee SA, and Vegetal SAS.
Mr. Levi received his undergraduate degree from École Nationale Supérieure des Mines de Paris and his MBA from The Wharton School of the University of Pennsylvania.


Picture Yaron Levi
Yaron Levi

Yaron R.
Levi
is currently the Chief Information Security Officer at Dolby Laboratories, Inc. He is also an Advisor at YL Ventures LLC, Safebreach, Inc., Capri Ventures LLC, Cyberstarts VC, and Silicon Valley CISO Investments.
In addition, he is an Advisor at Glilot Capital Investments GP Ltd.
and currently holds advisory positions at NTT Security AppSec Solutions, Inc., Optiv, Inc., and IntSights Cyber Intelligence Ltd.
Previously, he worked as the Director of Information Security at Cerner Corp., Director at TTI Telecom International Ltd., Principal & Information Security Business Partner at Intuit, Inc., and as a Member of the Board of Advisors at NTT Security AppSec Solutions, Inc., Optiv, Inc., and IntSights Cyber Intelligence Ltd.


Picture Avi Levi
Avi Levi

Avi Levi is currently the Chief Executive Officer at Israel Discount Bank Ltd.
He previously served as the Chairman at IDB (Swiss) Bank Ltd.
and Discount Trust Ltd.
Mr. Levi received his undergraduate degree from Tel-Aviv University in 1991 and his MBA from Bar-Ilan University in 2005.




Picture David A. Garraway
David A. Garraway

David A.
Garraway
currently works as a Director at Vroom Automotive Finance Corp.


Picture Elma Garraway
Elma Garraway

Elma Garraway currently works at Doctors Hospital Health System Ltd., as Director.




Picture Alvin R. Garraway
Alvin R. Garraway

Alvin R.
Garraway
is a Director of Valley Bancorp (Nevada) and a Member of the Nevada Society of CPAs and The American Institute of Certified Public Accountants.
Prior to joining Valley Bancorp (Nevada) in April 19, 2006, he was President and Controller of Oasis Residential, Inc. and an Audit Partner of Horwath Velez & Co. PSC.
He is a Certified Public Accountant.


















Picture Shaul Levi
Shaul Levi

Shaul Levi was the founder of Gilian Technologies Ltd.
which was founded in 1998 where he held the title of CTO from 1998 to 2003.
Mr. Levi's current job is as a Venture Partner at Flashpoint Venture Capital since 2018.
Mr. Levi's former jobs include being the Chief Executive Officer at Sightix Ltd.
from 2004 to 2011, Chief Strategy Officer at Avast Software NV from 2016 to 2018, and Chief Scientist at AVG Technologies USA, Inc. Mr. Levi received an MBA from Tel-Aviv University in 1998 and an undergraduate degree from Technion-Israel Institute of Technology.


Picture Igor Levi
Igor Levi

Igor Levi worked as a Director & Analyst at BTIG LLC from 2018 to 2022 and as a Research Associate at Morgan Stanley & Co. LLC from 2007 to 2018.



Picture Joseph Levi
Joseph Levi

Joseph Levi formerly worked at Mustang Alliances, Inc., as Chairman, President, CEO & Treasurer in 2010.
Mr. Levi received his undergraduate degree in 1999 from Bar-Ilan University.







Picture Sergio Levi
Sergio Levi

Sergio Levi is a SPARK Venture Director on the ICT team, specializing in the Semiconductor and Electronics sector.
He brings to SPARK a deep understanding of commercialising technology in complex value chains and in exploiting technology transitions to create market value.
He originally joined Quester in 2006 and prior to that spent 6 years as Vice President - Europe, Middle East and Africa at ON Semiconductor, a spin-off from the former Motorola Semiconductor Group.
Prior to ON Semiconductor, he had a 12-year career at Texas Instruments, the world's leader in digital signal processing and analog technologies, where he ran the company’s sales and marketing group in the South Europe region.
An Italian national, educated in the USA, Sergio also has an MBA from INSEAD.





Picture Yair Levi
Yair Levi

Yair Levi is currently the Director at Prime Energy P.E.
Ltd.
and the Chief Financial Officer at Hamat Group Ltd.
He previously worked as the Chief Financial Officer at Mendelson Infrastructure & Industries Ltd.
Mr. Levi received an undergraduate degree and an MBA from The College of Management Academic Studies in 2005.





Picture David Levi
David Levi

Mr. David Levi is a Chief Executive Officer & Director at Ethernity Networks Ltd.
He is on the Board of Directors at Ethernity Networks Ltd.
Mr. Levi was previously employed as a Co-Founder by BroadLight, Inc., a Co-Founder by BroadLight Ltd., a Director-Product Marketing by ECI Telecom Ltd., a Senior Manager-Product Line by RAD Data Communications Ltd., a Manager-Product Line Sales by Tadiran Communications Ltd., a Sales Manager by Dynamode Ltd., and a Systems Engineer & Project Manager by Israel Defense Forces.
He received his undergraduate degree from The Jerusalem College of Technology and an MBA from Bar-Ilan University.





Picture Yehuda Levi
Yehuda Levi

Yehuda Levi is currently the Chief Executive Officer & Owner at Renaissance City Park Ltd.
He is also a Director at Best Gofer, Inc. and M.A.G Financial Consulting Ltd.
Previously, he served as the Chief Executive Officer & Country Manager at HSBC Bank Plc (Israel) from 2001 to 2013.
He was also an Independent External Director at Israel Discount Bank Ltd.
from 2014 to 2019.
Additionally, he was the Chief Operating Officer & Director at BestGofer, Inc. and Vice President at Republic Bank of New York from 1981 to 1986.
Mr. Levi holds an MBA from Baruch College and an undergraduate degree from Technion-Israel Institute of Technology.




Picture Alessandro Levi
Alessandro Levi

Alessandro Levi founded Sensing Electromagnetic Plus Corp.
in 2013, where he is working as Chief Executive Officer from 2015 and Semplus Corp.
in 2013, where he worked as CEO, CFO & Director from 2013 to 2020.
Dr. Levi also formerly worked at Prime Movers Lab LLC, as Partner.
Dr. Levi received his undergraduate degree and graduate degree from the University of Pisa and doctorate degree from Scuola Superiore Sant'anna.






Picture Levi Fisher
Levi Fisher

Levi D.
Fisher
is currently a Director at Equitable Financial Corp.
and Director & President-Community Bank at Equitable Bank.
He was previously a Director at Equitable Financial MHC.
He obtained an undergraduate degree from the Board of Trustees NE State Colleges.




Picture Levi Rosenblum
Levi Rosenblum

Levi Rosenblum is the founder of 1st Merchant Funding LLC, a company he founded in 2007.
He currently holds the title of Chairman at the company.




Picture Levi James Cottington
Levi James Cottington

Levi James Cottington currently works at R M Lucas Co., as Chief Executive Officer from 2022 and The Amber Chemical Co. Ltd., as Director from 2017.
Mr. Cottington also formerly worked at ICM Products, Inc., as Chief Executive Officer from 2016 to 2022, ICM Silicones Group, as Chief Executive Officer, and ACC Silicones Ltd., as Director.
Mr. Cottington received his undergraduate degree from Drake University.






Picture Laurence W. Levi
Laurence W. Levi

Laurence W.
Levi
is the founder of VO2 Partners LLC.
He is currently a Director at WeLivv, Inc. and was previously the Chief Strategy Officer at The Flowr Corp.
from 2019 to 2020.
He received his undergraduate degree from the University of Wisconsin and his graduate degree from Columbia Law School.







Picture Moshe Levi
Moshe Levi

Moshe Levi is the founder of Jobox, Inc. which was founded in 2016.


Picture Dan Levi
Dan Levi

Dan Levi is currently the Director at Traffic Audit Bureau for Media Measurement, Inc. and the Executive Vice President & Chief Marketing Officer at Clear Channel Outdoor, Inc. He previously worked as the Chief Marketing Officer & Executive Vice President at Clear Channel Outdoor Holdings, Inc., Principal at World Wrestling Entertainment LLC, Paramount Media Networks, Captivate LLC, Zoom Media Corp., and Foundit.in.
Mr. Levi completed his undergraduate degree from The Pennsylvania State University in 1987.
















Picture Lorenzo Levi
Lorenzo Levi

Lorenzo Ilan Levi is currently the Chairman at Datamars Agri UK Ltd., Managing Director and Operating Partner at CDP Capital Private Equity (UK), Board Member at Emeria Europe SAS, and Board Member at Fives SA. Previously, he held positions such as Director-Corporate Development & Ventures at Nortel Networks, Director at Moorgate Industries Ltd., Operational Managing Director at Terra Firma Capital Partners Ltd., Director at Autobahn Tank & Rast Beteiligungs GmbH, Director at Phoenix Natural Gas Ltd., Director at ODEON & UCI Cinemas Holdings Ltd., Non-Executive Director at Wyevale Garden Centres Ltd., Non-Executive Director at Phoenix Energy Holdings Ltd., Non-Executive Director at AWAS Aviation Capital DAC, and Principal at International Business Machines Corp.
and Bain & Co., Inc. Mr. Levi received his undergraduate degree from Massachusetts Institute of Technology and his MBA from Harvard Business School.






Picture Julie Levi
Julie Levi

Julie Levi is the founder and CEO of Progressive Promotions, Inc. which was founded in 1987.
She is currently a member of Women Presidents' Organization.
Ms. Levi completed her undergraduate degree at Rutgers State University of New Jersey.



Picture Andrew Stuart Levi
Andrew Stuart Levi

Mr. Andrew S.
Levi is a Portfolio Manager at HITE Hedge Asset Management LLC.
He has 30-years of investment experience with expertise in utilities, power, natural gas and cleantech sectors and has a track record of over 20 years as a portfolio manager in these sectors.
Mr. Levi joined the firm after spending the last nine years at ExodusPoint Capital and Millennium.
Previously, he joined Brencourt in 2007.
In 2001 he began managing capital in the energy sector for Bear Stearns, working closely with the late John Mulheren.
His career began as a sell-side utilities analyst at Morgan Stanley, Furman Selz and Credit Suisse in the 1990’s, becoming a top ranked analyst in the sector.
He graduated with a BS in Finance from Fairleigh Dickinson University in 1988.




No results for this search